Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Phase I/II, open-label, dose escalation trial to evaluate the safety, pharmacokinetics, and pharmacodynamics of RAF265 (CHIR-265) administered orally to patients with locally advanced or metastatic melanoma https://kusajili.com:443/Trial/wtVN3HbeaUKo1mejO1Ha8g%24a-phase-iii-open-label-dose-escalation-trial-to-evaluate-the-safety-pharmacokinetics-and-pharmacodynamics-of-raf265-chir-265-ad
I have read and accept the terms of use of the site and the Privacy Policy
Send your message